Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.
about
Risk factors for etiology and prognosis of mantle cell lymphomaThe EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma.Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines.Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsThe copper chelator ATN-224 induces caspase-independent cell death in diffuse large B cell lymphomaIntegrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and oldAssociation of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortiumFas-associated factor 1 inhibits tumor growth by suppressing Helicobacter pylori-induced activation of NF-κB signaling in human gastric carcinomaMantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.Recent advances in mantle cell lymphoma: report of the 2012 Mantle Cell Lymphoma Consortium Workshop.An integrated Bayesian analysis of LOH and copy number data.Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignanciesEpigenetic activation of SOX11 in lymphoid neoplasms by histone modifications.The expression of FAS-associated factor 1 and heat shock protein 70 in ovarian cancer.Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphomaNon-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease.p97-containing complexes in proliferation control and cancer: emerging culprits or guilt by association?Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic eraNumerical and structural genomic aberrations are reliably detectable in tissue microarrays of formalin-fixed paraffin-embedded tumor samples by fluorescence in-situ hybridization.Fas-associated factor (Faf1) is a novel CD40 interactor that regulates CD40-induced NF-κB activation via a negative feedback loop.Common genetic variants related to genomic integrity and risk of papillary thyroid cancerAcquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expressionInvestigation of Rho-Kinase Expressions and Polymorphisms in Mantle Cell Lymphoma Patients.Relax with CouchDB--into the non-relational DBMS era of bioinformaticsPatterns of somatic uniparental disomy identify novel tumor suppressor genes in colorectal cancer.Fas-associated factor 1 is a scaffold protein that promotes β-transducin repeat-containing protein (β-TrCP)-mediated β-catenin ubiquitination and degradationMolecular pathogenesis of mantle cell lymphoma.Arsenic trioxide rewires mantle cell lymphoma response to bortezomibIntegrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer.Reduced FAF1 Expression and Helicobacter Infection: Correlations with Clinicopathological Features in Gastric Cancer.Chromatin-associated degradation is defined by UBXN-3/FAF1 to safeguard DNA replication fork progression.CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.Role of p97/VCP (Cdc48) in genome stability.ATM deficiency sensitizes mantle cell lymphoma cells to poly(ADP-ribose) polymerase-1 inhibitors.Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical featuresNew developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008.Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.FAS-associated factor 1 (FAF1): diverse functions and implications for oncogenesis.
P2860
Q26858960-36192429-DEB7-40F8-9155-C768891E002AQ27852536-BF3ED8A0-C22B-459C-9014-5EAE81247AD8Q27853007-D4445FB7-93C3-4B72-B47A-9AE4ADC997F6Q28075606-605509A4-0567-40B5-8C4A-F4DC7AB197EEQ28389285-EEE75F53-D221-4E50-B022-4608FE15A297Q28396741-0EF4BBAD-5B4C-4772-8659-B171D7F8114BQ28943463-7E726DD4-617E-4297-95A7-1FE99569D36DQ30275138-525B3AA8-0911-49EF-AF14-B7947B0180D5Q30452448-6ACB1F76-DB9D-4A0A-8B2D-B2BFAA5F5ED6Q30456436-E702AEEF-1A05-4865-823A-CE738CF7D7C3Q33605291-256C39BB-2EEB-4864-BAEC-3D6864F49BAFQ33788643-897FAFE9-68BE-4E34-8EBA-B130EE42F8E9Q33954847-A2138671-5D93-4F27-8A90-4CB39D1A7066Q34011778-6C9AB75A-3766-4F0C-88A1-0B5A1D2C97A3Q34074921-73475EBE-62EE-4DB3-9282-4F0614FA65EEQ34135450-498817F5-5894-4AF5-82DD-D1E89DB4F2B0Q34231288-3478E5D2-13B2-489C-AFB2-1EF59EECC235Q34318246-599AB22F-FE8C-4B90-99A3-3F449A197245Q34568868-7617E8FB-F40B-47F3-A605-9E76F256497BQ35148096-7D722A01-DAD1-4767-B7CE-45162040FBD6Q35165371-68004CD4-5D52-4F15-B62D-1AA685B29F05Q35193949-F72CFF69-67C2-431F-847F-F3632A7C0A31Q35220403-DB07ABDE-9D21-4206-B06F-260AAA67EAA5Q35476235-E74B6FEB-300A-4D12-B119-48D6B1894B0EQ35777721-DC9CAEFD-EF85-45B8-90DE-8C5BA8DAD37BQ36060622-9277C47C-50C6-4EC3-B24E-DCF5D34DC0F8Q36139202-256FE3EA-BF61-4634-964C-338E2B49432BQ36216463-E86D8765-637F-4578-9D7E-D900039525A1Q36290246-441FABE1-F8D1-41F6-A0B8-A8D71A9A459DQ36358595-20206481-05FB-4683-932C-3BD0864E55D2Q36487126-F34E7793-D8EA-4E24-B12E-7602522A5A34Q36488654-54E7303B-6CD6-4297-9F1F-81D15B558FDDQ36549348-D7E490F5-603B-4F42-84AE-E0B080E3CCD5Q36628297-ABBBEAD1-6B2A-42E5-B83E-DE50441D2943Q36804013-C8D5D442-C871-443A-84BE-C69B83242EBAQ37059580-546F3266-4ABB-4639-9B7D-B780B6713392Q37149519-A9F28577-ECD0-46A5-B58D-3D1EC599E13BQ37269044-644B85E8-BD24-4845-9688-B74E5A829BE6Q37318226-12CC1759-C7EF-4B76-B288-9844561452BCQ37549806-F1F4C357-CF1A-4C9B-8645-03EB43B07330
P2860
Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Uniparental disomies, homozygo ...... lution whole-genome profiling.
@en
Uniparental disomies, homozygo ...... lution whole-genome profiling.
@nl
type
label
Uniparental disomies, homozygo ...... lution whole-genome profiling.
@en
Uniparental disomies, homozygo ...... lution whole-genome profiling.
@nl
prefLabel
Uniparental disomies, homozygo ...... lution whole-genome profiling.
@en
Uniparental disomies, homozygo ...... lution whole-genome profiling.
@nl
P2093
P2860
P50
P1433
P1476
Uniparental disomies, homozygo ...... olution whole-genome profiling
@en
P2093
Andreas Rosenwald
Elena M Hartmann
German Ott
Lluís Armengol
Magda Pinyol
Verónica Fernández
Virginia Amador
P2860
P304
P356
10.1182/BLOOD-2008-07-170183
P407
P50
P577
2008-11-04T00:00:00Z